Physician
Asghar, Mir
Asghar, Mir was paid $89K by Medicaid between Sep 2021 and Oct 2024, across 8 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 73% of everything it billed.
33Billing provider infoASGHAR, MIR
HOWELL, MI 48843
HOWELL, MI 48843
33aNPI1194752543assigned 06/28/2006
33bProvider typeRheumatology Physician
28Total paid$89K
24GClaims1,290
24DCodes billed8
24AFirst – last monthSep 2021 – Oct 2024
Compared with peers
Next to other Rheumatology Physician providers in Michigan
Rank by total paid#16 of 39
Median peer was paid$37K
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 97 | $4K | |
| 2022 | 133 | $9K | |
| 2023 | 610 | $44K | |
| 2024incomplete | 450 | $32K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 73% | 849 | 653 | $65K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 19% | 178 | 178 | $17K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.5% | 75 | 75 | $2K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.5% | 34 | 33 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 88 | 84 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 41 | 41 | $562.11 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 13 | 12 | $552.37 |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 12 | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.